Correlation Between Merck KGaA and MGC Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck KGaA and MGC Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck KGaA and MGC Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck KGaA ADR and MGC Pharmaceuticals, you can compare the effects of market volatilities on Merck KGaA and MGC Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck KGaA with a short position of MGC Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck KGaA and MGC Pharmaceuticals.

Diversification Opportunities for Merck KGaA and MGC Pharmaceuticals

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Merck and MGC is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Merck KGaA ADR and MGC Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MGC Pharmaceuticals and Merck KGaA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck KGaA ADR are associated (or correlated) with MGC Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MGC Pharmaceuticals has no effect on the direction of Merck KGaA i.e., Merck KGaA and MGC Pharmaceuticals go up and down completely randomly.

Pair Corralation between Merck KGaA and MGC Pharmaceuticals

Assuming the 90 days horizon Merck KGaA ADR is expected to under-perform the MGC Pharmaceuticals. But the pink sheet apears to be less risky and, when comparing its historical volatility, Merck KGaA ADR is 28.96 times less risky than MGC Pharmaceuticals. The pink sheet trades about -0.01 of its potential returns per unit of risk. The MGC Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  0.78  in MGC Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of  20.22  from holding MGC Pharmaceuticals or generate 2592.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy80.2%
ValuesDaily Returns

Merck KGaA ADR  vs.  MGC Pharmaceuticals

 Performance 
       Timeline  
Merck KGaA ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck KGaA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
MGC Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MGC Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, MGC Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Merck KGaA and MGC Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck KGaA and MGC Pharmaceuticals

The main advantage of trading using opposite Merck KGaA and MGC Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck KGaA position performs unexpectedly, MGC Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MGC Pharmaceuticals will offset losses from the drop in MGC Pharmaceuticals' long position.
The idea behind Merck KGaA ADR and MGC Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments